English

CardioGenics Holdings Inc.

EDGAR

CGNH Quarterly report (10-Q) · filed 2016-03-28

79 filing records in this dataset, filed from 2000-03-16 to 2016-03-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2013 Q3 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-568 thousand USD

2013 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -623433 USD Source
Operating Cash Flow: -55179 USD Source

Cash and cash equivalents: 96.8 thousand USD 2016-01-31 Source
Exact value

96810 USD
Long-term debt including current maturities: 205 thousand USD 2013-04-30 Source
Exact value

204633 USD
Shares outstanding: 92.9 million shares 2016-01-31 Source
Exact value

92866724 shares

Reported share-count change

59.29% · 34.6 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

58300597 shares · 2015-01-31· Source
92866724 shares · 2016-01-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

161 USD

2012-08-01 – 2013-07-31

Exact inputs and evidence

Revenue: 1297 USD · 2011-11-01 – 2012-10-31 Source
Revenue: 1136 USD · 2011-11-01 – 2012-07-31 Source
Revenue: 0 USD · 2012-11-01 – 2013-01-31 Source
Revenue: 0 USD · 2013-02-01 – 2013-04-30 Source
Revenue: 0 USD · 2013-05-01 – 2013-07-31 Source

Net income

-981 thousand USD

2015-02-01 – 2016-01-31

Exact inputs and evidence

Net income: 123123 USD · 2015-02-01 – 2015-04-30 Source
Net income: -611490 USD · 2015-05-01 – 2015-07-31 Source
Net income: -1916324 USD · 2014-11-01 – 2015-10-31 Source
Net income: -1549197 USD · 2014-11-01 – 2015-07-31 Source
Net income: -125292 USD · 2015-11-01 – 2016-01-31 Source

Operating cash flow

-366 thousand USD

2015-02-01 – 2016-01-31

Exact inputs and evidence

Operating cash flow: -310738 USD · 2014-11-01 – 2015-04-30 Source
Operating cash flow: -210170 USD · 2014-11-01 – 2015-01-31 Source
Operating cash flow: -473486 USD · 2014-11-01 – 2015-07-31 Source
Operating cash flow: -310738 USD · 2014-11-01 – 2015-04-30 Source
Operating cash flow: -606639 USD · 2014-11-01 – 2015-10-31 Source
Operating cash flow: -473486 USD · 2014-11-01 – 2015-07-31 Source
Operating cash flow: 30061 USD · 2015-11-01 – 2016-01-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-03-28.

Financial data available through: 2015-10-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2012-10-31
Operating income: 6 of 11 periods available· newest 2015-10-31
Net income: 11 of 11 periods available· newest 2015-10-31
Operating cash flow: 8 of 11 periods available· newest 2015-10-31
Capital expenditure: 6 of 11 periods available· newest 2013-10-31
Total assets: 8 of 11 periods available· newest 2015-10-31
Total liabilities: 9 of 11 periods available· newest 2014-10-31
Current assets: 10 of 11 periods available· newest 2015-10-31
Current liabilities: 11 of 11 periods available· newest 2015-10-31
Cash and cash equivalents: 11 of 11 periods available· newest 2015-10-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2012-10-31
Shares outstanding: 3 of 11 periods available· newest 2015-10-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 763,552

Prior period

−USD 2.68 million

2013-11-01 – 2014-10-31
Current period

−USD 1.92 million

2014-11-01 – 2015-10-31

Exact inputs and evidence

-1916324 − -2679876 = 763552 USD

-2679876 USD · 2013-11-01 – 2014-10-31
Inspect prior input Prior source
-1916324 USD · 2014-11-01 – 2015-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CardioGenics Holdings Inc. · 2015-10-31 CardioGenics Holdings Inc. (edgar:1089029) Year-over-year change in Net income: 763552 USD Concept: fundies:NetIncome Period: 2014-11-01 to 2015-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1916324 USD (2014-11-01 to 2015-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315216007687/cgnh-20151031.xml#129163 Filing: 000149315216007687 Input fundies:NetIncome: -2679876 USD (2013-11-01 to 2014-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315216007687/cgnh-20151031.xml#129710 Filing: 000149315216007687
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 9,528

Prior period

−USD 597,111

2013-11-01 – 2014-10-31
Current period

−USD 606,639

2014-11-01 – 2015-10-31

Exact inputs and evidence

-606639 − -597111 = -9528 USD

-597111 USD · 2013-11-01 – 2014-10-31
Inspect prior input Prior source
-606639 USD · 2014-11-01 – 2015-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CardioGenics Holdings Inc. · 2015-10-31 CardioGenics Holdings Inc. (edgar:1089029) Year-over-year change in Operating cash flow: -9528 USD Concept: fundies:OperatingCashFlow Period: 2014-11-01 to 2015-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -606639 USD (2014-11-01 to 2015-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315216007687/cgnh-20151031.xml#478582 Filing: 000149315216007687 Input fundies:OperatingCashFlow: -597111 USD (2013-11-01 to 2014-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315216007687/cgnh-20151031.xml#478766 Filing: 000149315216007687
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2011-11-01 – 2012-10-31

Revenue USD 1,297 100% of revenue
Operating costs Derived USD 1.32 million 101,388% of revenue
Operating income −USD 1.31 million −101,288% of revenue
Tax, interest and other Derived −USD 5,660 −436% of revenue
Net income −USD 1.31 million −100,852% of revenue

Cash

Operating cash flow −USD 970,839 −74,853% of revenue
Capital expenditure USD 3,824 295% of revenue
Free cash flow Derived −USD 974,663 −75,147% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2011 Operating loss: operating costs were 63,767% of revenue.
2012 Operating loss: operating costs were 101,388% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2011 2010-11-01 – 2011-10-31	8876	5659922 Derived	-5651046	73570 Derived	-5724616	-1536184 Derived	Source 2010-11-01 – 2011-10-31: 8876 USD Inspect Revenue Open source 2010-11-01 – 2011-10-31: -5651046 USD Inspect Operating Income Open source 2010-11-01 – 2011-10-31: -5724616 USD Inspect Net Income Open source 2010-11-01 – 2011-10-31: -1520942 USD Inspect Operating Cash Flow Open source 2010-11-01 – 2011-10-31: 15242 USD Inspect Capital Expenditure Open source
2012 2011-11-01 – 2012-10-31	1297	1315006 Derived	-1313709	-5660 Derived	-1308049	-974663 Derived	Source 2011-11-01 – 2012-10-31: 1297 USD Inspect Revenue Open source 2011-11-01 – 2012-10-31: -1313709 USD Inspect Operating Income Open source 2011-11-01 – 2012-10-31: -1308049 USD Inspect Net Income Open source 2011-11-01 – 2012-10-31: -970839 USD Inspect Operating Cash Flow Open source 2011-11-01 – 2012-10-31: 3824 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.3K 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-10-31	Revenue	8876	Revenue: 8876 Open source
20122012-10-31	Revenue	1297	Revenue: 1297 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-85.4% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20112011-10-31	Year over year	No prior comparable period	Revenue: 8876 Open source
20122012-10-31	Year over year	-85.4%	Revenue: 1297 Open source Revenue: 8876 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -101,288.3% 2012

Net margin -100,851.9% 2012

Free cash flow margin -75,147.5% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20112011-10-31	Operating margin	-63,666.6%	Operating Income: -5651046 Open source Revenue: 8876 Open source
20122012-10-31	Operating margin	-101,288.3%	Operating Income: -1313709 Open source Revenue: 1297 Open source
20112011-10-31	Net margin	-64,495.4%	Net Income: -5724616 Open source Revenue: 8876 Open source
20122012-10-31	Net margin	-100,851.9%	Net Income: -1308049 Open source Revenue: 1297 Open source
20112011-10-31	Free cash flow margin	-17,307.2%	Revenue: 8876 Open source Operating Cash Flow: -1520942 Open source Capital Expenditure: 15242 Open source
20122012-10-31	Free cash flow margin	-75,147.5%	Revenue: 1297 Open source Operating Cash Flow: -970839 Open source Capital Expenditure: 3824 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -970.8K 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-10-31	Operating cash flow	-1520942	Operating Cash Flow: -1520942 Open source
20122012-10-31	Operating cash flow	-970839	Operating Cash Flow: -970839 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -974.7K 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-10-31	Free cash flow	-1536184	Operating Cash Flow: -1520942 Open source Capital Expenditure: 15242 Open source
20122012-10-31	Free cash flow	-974663	Operating Cash Flow: -970839 Open source Capital Expenditure: 3824 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

232.7% 2012

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20112011-10-31	Liabilities / assets	53.6%	Total Liabilities: 625037 Open source Total Assets: 1165473 Open source
20122012-10-31	Liabilities / assets	232.7%	Total Liabilities: 888766 Open source Total Assets: 382013 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.23× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20112011-10-31	Current assets / current liabilities	1.53×	Current Assets: 952433 Open source Current Liabilities: 622407 Open source
20122012-10-31	Current assets / current liabilities	0.23×	Current Assets: 204155 Open source Current Liabilities: 888766 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2005-11-01 – 2006-10-31	−USD 522,532 Exact value Exact value: -522532 USD 2005-11-01 – 2006-10-31: -522532 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2006-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -522532 USD Concept: fundies:NetIncome Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2006-10-31&surface=latest&period_type=duration&start=2005-11-01&unit=USD&dimensions= Input fundies:NetIncome: -522532 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#192579 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2006-11-01 – 2007-10-31	−USD 303,477 Exact value Exact value: -303477 USD 2006-11-01 – 2007-10-31: -303477 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2007-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -303477 USD Concept: fundies:NetIncome Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2007-10-31&surface=latest&period_type=duration&start=2006-11-01&unit=USD&dimensions= Input fundies:NetIncome: -303477 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#192705 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2007-11-01 – 2008-10-31	−USD 1.33 million Exact value Exact value: -1331408 USD 2007-11-01 – 2008-10-31: -1331408 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2008-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -1331408 USD Concept: fundies:NetIncome Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1331408 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#192831 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	USD 129,197 Exact value Exact value: 129197 USD 2007-11-01 – 2008-10-31: 129197 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CardioGenics Holdings Inc. · 2008-10-31 CardioGenics Holdings Inc. (edgar:1089029) Operating Cash Flow: 129197 USD Concept: fundies:OperatingCashFlow Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3AOperatingCashFlow&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 129197 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/0001144204-10-008094.txt#20041 The citation records this snapshot. The page link may show a newer release later.	USD 1,012 Exact value Exact value: 1012 USD 2007-11-01 – 2008-10-31: 1012 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CardioGenics Holdings Inc. · 2008-10-31 CardioGenics Holdings Inc. (edgar:1089029) Capital Expenditure: 1012 USD Concept: fundies:CapitalExpenditure Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ACapitalExpenditure&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1012 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/0001144204-10-008094.txt#20112 The citation records this snapshot. The page link may show a newer release later.	USD 128,185 Calculation and evidence 129197 − 1012 USD Exact free cash flow: 128185 USD 2007-11-01 – 2008-10-31: 129197 USD · Inspect Operating Cash Flow · Source 2007-11-01 – 2008-10-31: 1012 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CardioGenics Holdings Inc. · 2008-10-31 CardioGenics Holdings Inc. (edgar:1089029) Free cash flow: 128185 USD Concept: free-cash-flow Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 129197 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/0001144204-10-008094.txt#20041 Input fundies:CapitalExpenditure: 1012 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/0001144204-10-008094.txt#20112 The citation records this snapshot. The page link may show a newer release later.
2009 2008-11-01 – 2009-10-31	−USD 28.72 million Exact value Exact value: -28715913 USD 2008-11-01 – 2009-10-31: -28715913 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2009-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -28715913 USD Concept: fundies:NetIncome Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=USD&dimensions= Input fundies:NetIncome: -28715913 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#192958 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	−USD 734,780 Exact value Exact value: -734780 USD 2008-11-01 – 2009-10-31: -734780 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CardioGenics Holdings Inc. · 2009-10-31 CardioGenics Holdings Inc. (edgar:1089029) Operating Cash Flow: -734780 USD Concept: fundies:OperatingCashFlow Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3AOperatingCashFlow&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -734780 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/0001144204-11-005050.txt#22605 The citation records this snapshot. The page link may show a newer release later.	USD 8,950 Exact value Exact value: 8950 USD 2008-11-01 – 2009-10-31: 8950 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CardioGenics Holdings Inc. · 2009-10-31 CardioGenics Holdings Inc. (edgar:1089029) Capital Expenditure: 8950 USD Concept: fundies:CapitalExpenditure Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ACapitalExpenditure&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8950 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/0001144204-11-005050.txt#22675 The citation records this snapshot. The page link may show a newer release later.	−USD 743,730 Calculation and evidence -734780 − 8950 USD Exact free cash flow: -743730 USD 2008-11-01 – 2009-10-31: -734780 USD · Inspect Operating Cash Flow · Source 2008-11-01 – 2009-10-31: 8950 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CardioGenics Holdings Inc. · 2009-10-31 CardioGenics Holdings Inc. (edgar:1089029) Free cash flow: -743730 USD Concept: free-cash-flow Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -734780 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/0001144204-11-005050.txt#22605 Input fundies:CapitalExpenditure: 8950 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/0001144204-11-005050.txt#22675 The citation records this snapshot. The page link may show a newer release later.
2010 2009-11-01 – 2010-10-31	−USD 2.02 million Exact value Exact value: -2024272 USD 2009-11-01 – 2010-10-31: -2024272 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2010-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -2024272 USD Concept: fundies:NetIncome Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=USD&dimensions= Input fundies:NetIncome: -2024272 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#193086 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	−USD 2.16 million Exact value Exact value: -2162664 USD 2009-11-01 – 2010-10-31: -2162664 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CardioGenics Holdings Inc. · 2010-10-31 CardioGenics Holdings Inc. (edgar:1089029) Operating Cash Flow: -2162664 USD Concept: fundies:OperatingCashFlow Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3AOperatingCashFlow&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2162664 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000114420412022957/cgnh-20111031.xml#178163 Filing: 000114420412022957 The citation records this snapshot. The page link may show a newer release later.	USD 11,058 Exact value Exact value: 11058 USD 2009-11-01 – 2010-10-31: 11058 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CardioGenics Holdings Inc. · 2010-10-31 CardioGenics Holdings Inc. (edgar:1089029) Capital Expenditure: 11058 USD Concept: fundies:CapitalExpenditure Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ACapitalExpenditure&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11058 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000114420412022957/cgnh-20111031.xml#181854 Filing: 000114420412022957 The citation records this snapshot. The page link may show a newer release later.	−USD 2.17 million Calculation and evidence -2162664 − 11058 USD Exact free cash flow: -2173722 USD 2009-11-01 – 2010-10-31: -2162664 USD · Inspect Operating Cash Flow · Source 2009-11-01 – 2010-10-31: 11058 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CardioGenics Holdings Inc. · 2010-10-31 CardioGenics Holdings Inc. (edgar:1089029) Free cash flow: -2173722 USD Concept: free-cash-flow Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2162664 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000114420412022957/cgnh-20111031.xml#178163 Filing: 000114420412022957 Input fundies:CapitalExpenditure: 11058 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000114420412022957/cgnh-20111031.xml#181854 Filing: 000114420412022957 The citation records this snapshot. The page link may show a newer release later.
2011 2010-11-01 – 2011-10-31	−USD 5.72 million Exact value Exact value: -5724616 USD 2010-11-01 – 2011-10-31: -5724616 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2011-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -5724616 USD Concept: fundies:NetIncome Period: 2010-11-01 to 2011-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2011-10-31&surface=latest&period_type=duration&start=2010-11-01&unit=USD&dimensions= Input fundies:NetIncome: -5724616 USD (2010-11-01 to 2011-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#188416 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	−USD 1.52 million Exact value Exact value: -1520942 USD 2010-11-01 – 2011-10-31: -1520942 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CardioGenics Holdings Inc. · 2011-10-31 CardioGenics Holdings Inc. (edgar:1089029) Operating Cash Flow: -1520942 USD Concept: fundies:OperatingCashFlow Period: 2010-11-01 to 2011-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3AOperatingCashFlow&period=2011-10-31&surface=latest&period_type=duration&start=2010-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1520942 USD (2010-11-01 to 2011-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000114420413017122/cgnh-20121031.xml#621183 Filing: 000114420413017122 The citation records this snapshot. The page link may show a newer release later.	USD 15,242 Exact value Exact value: 15242 USD 2010-11-01 – 2011-10-31: 15242 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CardioGenics Holdings Inc. · 2011-10-31 CardioGenics Holdings Inc. (edgar:1089029) Capital Expenditure: 15242 USD Concept: fundies:CapitalExpenditure Period: 2010-11-01 to 2011-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ACapitalExpenditure&period=2011-10-31&surface=latest&period_type=duration&start=2010-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15242 USD (2010-11-01 to 2011-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000114420413017122/cgnh-20121031.xml#622150 Filing: 000114420413017122 The citation records this snapshot. The page link may show a newer release later.	−USD 1.54 million Calculation and evidence -1520942 − 15242 USD Exact free cash flow: -1536184 USD 2010-11-01 – 2011-10-31: -1520942 USD · Inspect Operating Cash Flow · Source 2010-11-01 – 2011-10-31: 15242 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CardioGenics Holdings Inc. · 2011-10-31 CardioGenics Holdings Inc. (edgar:1089029) Free cash flow: -1536184 USD Concept: free-cash-flow Period: 2010-11-01 to 2011-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1520942 USD (2010-11-01 to 2011-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000114420413017122/cgnh-20121031.xml#621183 Filing: 000114420413017122 Input fundies:CapitalExpenditure: 15242 USD (2010-11-01 to 2011-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000114420413017122/cgnh-20121031.xml#622150 Filing: 000114420413017122 The citation records this snapshot. The page link may show a newer release later.
2012 2011-11-01 – 2012-10-31	−USD 1.31 million Exact value Exact value: -1308049 USD 2011-11-01 – 2012-10-31: -1308049 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2012-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -1308049 USD Concept: fundies:NetIncome Period: 2011-11-01 to 2012-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2012-10-31&surface=latest&period_type=duration&start=2011-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1308049 USD (2011-11-01 to 2012-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#188292 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	−USD 970,839 Exact value Exact value: -970839 USD 2011-11-01 – 2012-10-31: -970839 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CardioGenics Holdings Inc. · 2012-10-31 CardioGenics Holdings Inc. (edgar:1089029) Operating Cash Flow: -970839 USD Concept: fundies:OperatingCashFlow Period: 2011-11-01 to 2012-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3AOperatingCashFlow&period=2012-10-31&surface=latest&period_type=duration&start=2011-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -970839 USD (2011-11-01 to 2012-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#262653 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	USD 3,824 Exact value Exact value: 3824 USD 2011-11-01 – 2012-10-31: 3824 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CardioGenics Holdings Inc. · 2012-10-31 CardioGenics Holdings Inc. (edgar:1089029) Capital Expenditure: 3824 USD Concept: fundies:CapitalExpenditure Period: 2011-11-01 to 2012-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ACapitalExpenditure&period=2012-10-31&surface=latest&period_type=duration&start=2011-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3824 USD (2011-11-01 to 2012-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#264236 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.	−USD 974,663 Calculation and evidence -970839 − 3824 USD Exact free cash flow: -974663 USD 2011-11-01 – 2012-10-31: -970839 USD · Inspect Operating Cash Flow · Source 2011-11-01 – 2012-10-31: 3824 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CardioGenics Holdings Inc. · 2012-10-31 CardioGenics Holdings Inc. (edgar:1089029) Free cash flow: -974663 USD Concept: free-cash-flow Period: 2011-11-01 to 2012-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -970839 USD (2011-11-01 to 2012-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#262653 Filing: 000149315214000437 Input fundies:CapitalExpenditure: 3824 USD (2011-11-01 to 2012-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315214000437/cgnh-20131031.xml#264236 Filing: 000149315214000437 The citation records this snapshot. The page link may show a newer release later.
2013 2012-11-01 – 2013-10-31	−USD 2.92 million Exact value Exact value: -2918647 USD 2012-11-01 – 2013-10-31: -2918647 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2013-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -2918647 USD Concept: fundies:NetIncome Period: 2012-11-01 to 2013-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2013-10-31&surface=latest&period_type=duration&start=2012-11-01&unit=USD&dimensions= Input fundies:NetIncome: -2918647 USD (2012-11-01 to 2013-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315215000488/cgnh-20141031.xml#128419 Filing: 000149315215000488 The citation records this snapshot. The page link may show a newer release later.	−USD 718,553 Exact value Exact value: -718553 USD 2012-11-01 – 2013-10-31: -718553 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CardioGenics Holdings Inc. · 2013-10-31 CardioGenics Holdings Inc. (edgar:1089029) Operating Cash Flow: -718553 USD Concept: fundies:OperatingCashFlow Period: 2012-11-01 to 2013-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3AOperatingCashFlow&period=2013-10-31&surface=latest&period_type=duration&start=2012-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -718553 USD (2012-11-01 to 2013-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315215000488/cgnh-20141031.xml#506309 Filing: 000149315215000488 The citation records this snapshot. The page link may show a newer release later.	USD 153 Exact value Exact value: 153 USD 2012-11-01 – 2013-10-31: 153 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CardioGenics Holdings Inc. · 2013-10-31 CardioGenics Holdings Inc. (edgar:1089029) Capital Expenditure: 153 USD Concept: fundies:CapitalExpenditure Period: 2012-11-01 to 2013-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ACapitalExpenditure&period=2013-10-31&surface=latest&period_type=duration&start=2012-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 153 USD (2012-11-01 to 2013-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315215000488/cgnh-20141031.xml#508083 Filing: 000149315215000488 The citation records this snapshot. The page link may show a newer release later.	−USD 718,706 Calculation and evidence -718553 − 153 USD Exact free cash flow: -718706 USD 2012-11-01 – 2013-10-31: -718553 USD · Inspect Operating Cash Flow · Source 2012-11-01 – 2013-10-31: 153 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CardioGenics Holdings Inc. · 2013-10-31 CardioGenics Holdings Inc. (edgar:1089029) Free cash flow: -718706 USD Concept: free-cash-flow Period: 2012-11-01 to 2013-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -718553 USD (2012-11-01 to 2013-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315215000488/cgnh-20141031.xml#506309 Filing: 000149315215000488 Input fundies:CapitalExpenditure: 153 USD (2012-11-01 to 2013-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315215000488/cgnh-20141031.xml#508083 Filing: 000149315215000488 The citation records this snapshot. The page link may show a newer release later.
2014 2013-11-01 – 2014-10-31	−USD 2.68 million Exact value Exact value: -2679876 USD 2013-11-01 – 2014-10-31: -2679876 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2014-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -2679876 USD Concept: fundies:NetIncome Period: 2013-11-01 to 2014-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2014-10-31&surface=latest&period_type=duration&start=2013-11-01&unit=USD&dimensions= Input fundies:NetIncome: -2679876 USD (2013-11-01 to 2014-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315216007687/cgnh-20151031.xml#129710 Filing: 000149315216007687 The citation records this snapshot. The page link may show a newer release later.	−USD 597,111 Exact value Exact value: -597111 USD 2013-11-01 – 2014-10-31: -597111 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CardioGenics Holdings Inc. · 2014-10-31 CardioGenics Holdings Inc. (edgar:1089029) Operating Cash Flow: -597111 USD Concept: fundies:OperatingCashFlow Period: 2013-11-01 to 2014-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3AOperatingCashFlow&period=2014-10-31&surface=latest&period_type=duration&start=2013-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -597111 USD (2013-11-01 to 2014-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315216007687/cgnh-20151031.xml#478766 Filing: 000149315216007687 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-11-01 – 2015-10-31	−USD 1.92 million Exact value Exact value: -1916324 USD 2014-11-01 – 2015-10-31: -1916324 USD Inspect Net Income Open source Share or cite Citation for Net Income · CardioGenics Holdings Inc. · 2015-10-31 CardioGenics Holdings Inc. (edgar:1089029) Net Income: -1916324 USD Concept: fundies:NetIncome Period: 2014-11-01 to 2015-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3ANetIncome&period=2015-10-31&surface=latest&period_type=duration&start=2014-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1916324 USD (2014-11-01 to 2015-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315216007687/cgnh-20151031.xml#129163 Filing: 000149315216007687 The citation records this snapshot. The page link may show a newer release later.	−USD 606,639 Exact value Exact value: -606639 USD 2014-11-01 – 2015-10-31: -606639 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CardioGenics Holdings Inc. · 2015-10-31 CardioGenics Holdings Inc. (edgar:1089029) Operating Cash Flow: -606639 USD Concept: fundies:OperatingCashFlow Period: 2014-11-01 to 2015-10-31 Values: Latest reported Published: 2026-11-02T13:14:28Z Snapshot: 867848a9bd25102d91ecda0c4d9b403b0faf878e2c4f2edcf62d7f0f97500e67 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1089029/explain?concept=fundies%3AOperatingCashFlow&period=2015-10-31&surface=latest&period_type=duration&start=2014-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -606639 USD (2014-11-01 to 2015-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1089029/000149315216007687/cgnh-20151031.xml#478582 Filing: 000149315216007687 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

79 filings · 1,576 latest values · 1,576 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001089029, 1089029, CGNH, edgar:1089029

Also known as CARDIOGENICS HOLDINGS INC., CardioGenics Holdings Inc., JAG MEDIA HOLDINGS INC, JAGNOTES COM

CardioGenics Holdings Inc.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2012 2011-11-01 – 2012-10-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation